Treatment with KBP-089 and liraglutide reduces overall adiposity in high fat diet rats At study end adipose tissues were isolated and weighed
Diabetes Care 38:13391346 Smits MM, Tonneijck L, Muskiet MH et al (2016) Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Common sites include: Lower abdomen (most common) Upper thigh Upper arm Pinch a fold of skin, insert the needle at a 45-degree angle, and inject slowly over 2-3 seconds
- a randomized controlled trial
Novo Nordisk and Eli Lilly are both leaning into structured access models, partnerships, and employer-facing distribution
If your main goal is to lose deep belly fat and improve metabolism, tesamorelin may be the better fit